0Q1N.L - Pfizer Inc.

LSE - LSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3N/A
S&P500 52-week change 36.21%
52-week high 350.82
52-week low 350.26
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 85.64B
% held by insiders 10.03%
% held by institutions 170.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.61
Trailing annual dividend yield 33.18%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 301 July 1999

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)02 Apr 2023


Profit margin 31.25%
Operating margin (ttm)38.00%

Management effectiveness

Return on assets (ttm)11.63%
Return on equity (ttm)31.62%

Income statement

Revenue (ttm)92.95B
Revenue per share (ttm)16.56
Quarterly revenue growth (yoy)-28.80%
Gross profit (ttm)66.23B
Net income avi to common (ttm)29.03B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-29.50%

Balance sheet

Total cash (mrq)19.97B
Total cash per share (mrq)3.54
Total debt (mrq)36.17B
Total debt/equity (mrq)35.72
Current ratio (mrq)1.37
Book value per share (mrq)17.89

Cash flow statement

Operating cash flow (ttm)23.94B
Levered free cash flow (ttm)17.96B